Acutaas Chemicals Limited has released its latest corporate presentation, showcasing significant growth across its core business segments. The company reported a robust revenue of ₹13,394 million for FY26, driven by strong performance in its Pharmaceutical Intermediates and specialty chemical divisions. With over 610 products and 600 customers, the firm continues to scale its global operations through targeted capacity expansions and a commitment to innovation, reinforced by a massive ₹1000+ crore ongoing investment plan through FY30.
Financial Performance and Growth Trajectory
The company has demonstrated impressive financial growth, with total revenue rising to ₹13,394 million in FY26. Profitability has seen a significant surge, with PAT reaching ₹3,564 million, reflecting a 26.6% margin. The EBITDA performance was equally strong, standing at ₹4,804 million with a margin of 35.9%. This growth is supported by a FY20-25 CAGR of 33.2% in total revenue, underscoring the company’s successful scale-up strategy.
Strategic Business Segments
Acutaas Chemicals operates across four key segments:
- Pharmaceutical Intermediates: The primary revenue driver, contributing 88% of total revenue, with a global market share of 50-90% in key intermediates.
- Commodity Chemicals: Focused on portfolio diversification and replacing low-margin legacy products, this segment contributed ₹1,495 million in revenue.
- Semiconductor Chemicals: Representing a high-barrier niche, the company is India’s only manufacturer of photoresist chemicals.
- Battery Chemicals: A strategic entry point for energy storage, with 10+ products in the pipeline and established validation from over 5 customers.
Capital Expenditure and Future Outlook
The company is in the midst of an ambitious ₹1000+ crore investment cycle (FY23-FY30) to secure future growth. Major capital allocations include ₹320 crore for pharmaceutical capacity expansion, ₹220 crore for battery chemicals, and ₹200 crore dedicated to the Indichem Inc joint venture in South Korea for semiconductor chemicals. These investments are complemented by a focus on sustainable energy, with 16 MW of solar power capacity already installed to meet facility electricity requirements.
Innovation and People
Acutaas maintains a competitive edge through its R&D capabilities, supported by a team of over 130 professionals, including 30+ PhDs. The company has successfully filed 26 process patents and utilizes advanced technologies like continuous flow reaction to maintain its market position. With a young workforce and a commitment to sustainability, evidenced by its EcoVadis Platinum Accreditation, the company remains focused on its long-term objective of becoming a global leader in specialty and custom chemical solutions.
Source: BSE
